CELLTRION-HEALTHCARE
Celltrion Healthcare has partnered with a leading patient organisation, the European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA), to raise awareness of inflammatory bowel disease (IBD) this World IBD Day (19 May 2023).
The campaign, Where’s CC? (Crohn’s and Colitis), aims to spark conversations about the impact of IBD across people’s lives and how these challenges vary between different age groups.
People are being encouraged to find the hidden CC characters and learn more about the unique challenges they have faced from being diagnosed with IBD to finding a treatment that works for them, at different stages of life, based on real-life patient insights.
Over ten million people worldwide are living with IBD1, a group of conditions including Crohn’s disease and ulcerative colitis (UC). IBD is most commonly diagnosed between the ages of 10 and 401, however it can appear at any point during people’s lives, with 10% to 15% of newly diagnosed cases of IBD being over the age of 60.2
Clinical research, education and understanding however do not reflect this, leaving groups of people feeling left behind and underrepresented. This can impact patient’s ability to benefit from innovative treatment options and high-quality care, impacting their quality of life and disease outcomes.
Visit www.WhereisCC.com to learn more about the campaign and help in shining a light on IBD by finding CC and learning more about their unique experiences.
Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare, said: “Every IBD patient, no matter their age, deserves to feel understood and have access to high quality care and effective, innovative treatments. Innovations in treatments, including advances in treatment administration that enable people to access at-home injectable treatment allows people to have an improved quality of life whilst managing their condition. We are extremely proud to launch the Where’s CC? campaign in collaboration with EFCCA for World IBD Day 2023 to improve understanding of IBD and the challenges that are associated with specific stages of life.
“Through our partnership with EFCCA, we have unparalleled opportunity to turn the tide in IBD and ensure no patient feels alone or left behind in their unique journey.”
Salvo Leone, EFCCA Chairman, commented: “IBD has no age, yet people living with IBD are facing challenges associated with their age that prevent them benefitting from the best treatment options.
“This World IBD Day, we are delighted to have partnered with Celltrion Healthcare to spotlight some of these challenges to raise awareness and improve care for IBD patients across the world. The Where’s CC? campaign includes important patient resources, and we encourage everyone to spread the word as we work towards a situation where all IBD patients can have a good quality of life.”
Molly O’Donoghue, UC patient, said: “Being diagnosed with UC at 15, I thought I would never be able to move away to university or go travelling with my friends. I was on a downward spiral, becoming depressed and isolated, until I found an at-home treatment that gave me a new freedom to do these things as I had always wanted.
“It is so important that people with IBD are not ashamed of their condition, and we talk about the challenges that come with learning to live with the condition at different stages of life. The Where’s CC? campaign is a brilliant way to raise awareness and help people to overcome the challenges that IBD brings.”
- ENDS -
Notes to Editors:
About Inflammatory Bowel Disease (IBD)
IBD is an umbrella term used to describe conditions including Crohn’s disease and UC. Collectively, IBD impacts over ten million people worldwide.1
IBD is a long-term condition and there may be times when the symptoms are severe, known as a flare-up, and times where there are no or few symptoms, known as remission. Symptoms can be debilitating if the condition is not well managed. These often include abdominal pain and cramping, diarrhoea, weight loss and extreme tiredness.3
Treatment for IBD can be transformative in patients’ lives, reducing the impact of the condition on their lives by minimising flare-up of symptoms and maintaining remission. In recent years, the increasing availability of new treatments has transformed IBD patient care. Innovations in treatments, including advances in treatment administration that enable people to access at-home injectable treatment (versus hospital-based treatment), allows people to have an improved quality of life whilst managing their condition.
About Celltrion Healthcare
Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA Current Good Manufacturing Practice (cGMP) and the EU GMP guidelines. Celltrion Healthcare endeavours to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries. For more information, please visit: https://www.celltrionhealthcare.com
About EFCCA
The European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA) represents 46 national Crohn’s and ulcerative colitis (collectively known as Inflammatory Bowel Disease or IBD) patient associations. We are an organization of people united in our commitment to improve the life of over 10 million people living with IBD worldwide (3.4 million in Europe alone) and to give them a louder voice and more visibility. For more information, please visit: https://efcca.org/
References
1 EFCCA. What is IBD? Available at: https://efcca.org/content/what-ibd [Accessed May 2023]
2 EFCCA. World IBD Day 2023. Available at: https://efcca.org/projects/world-ibd-day-2023 [Accessed May 2023]
3 NHS. Inflammatory bowel disease. Available at: https://www.nhs.uk/conditions/inflammatory-bowel-disease/ [Accessed May 2023]
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005512/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand17.9.2025 13:30:00 CEST | Press release
Kinectrics, a division of BWX Technologies Inc. (NYSE: BWXT), announced today the completion of a major expansion to its isotope production capabilities, reinforcing its role as a global supplier of highly enriched stable isotopes and establishing the only North American source for Yb-176, reducing the reliance on foreign material for life-saving cancer treatments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917450864/en/ Travis Besanger, Kinectrics VP of Medical Isotopes, speaking within the new Isotope Separation Production Facility at Kinectrics Headquarters in Toronto, Canada. Kinectrics commissioned four new 2nd generation Electromagnetic Isotope Separator (EMIS) units, which will boost its annual production capacity to over 500 grams of Ytterbium-176 (Yb-176), the precursor for Lutetium-177 (Lu-177), by the end of the year. This scaled output will support over 150,000 patient treatments annually. Lu-177 is a medi
Kinaxis to Host Inaugural European User Conference Showcasing Supply Chain Innovators17.9.2025 13:00:00 CEST | Press release
Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced its inaugural customer conference in Europe. Kinexions EMEA 2025 will be held October 6 – 8 in Amsterdam NL, bringing together global supply chain leaders from ExxonMobil, Bosch, and more. Following the success of Kinexions conferences in North America and Asia, expanding Kinexions into Europe meets the needs of a growing customer community in the region and reflects the growing community of leaders in the region who are driving some of the most innovative and resilient supply chain transformations today. That momentum is reflected in Kinaxis’ 18% year-over-year revenue growth in Europe, underscoring rising demand for AI-driven orchestration on the Kinaxis Maestro® platform. Why It Matters As supply chains face ongoing pressure from the dynamic tariff environment, geopolitical risk, ESG regulation, and many other disruptions, companies are accelerating digital transformation efforts. Kin
Allied Telesis Launches SwitchBlade® x908 Generation 3 to Solve Enterprise and Data Center Scalability Challenges17.9.2025 11:40:00 CEST | Press release
Compact 3U modular chassis delivers capacity-on-demand flexibility and first Allied Telesis 400G support. Enterprises and data centers face mounting challenges in scaling their networks to support AI, video, IoT, and virtualized workloads. Bandwidth demand is rising, yet many organizations are held back by legacy switches, fragmented operations, and the high cost of oversized chassis systems. To address these issues, Allied Telesis today announced the SwitchBlade x908 Generation 3 (SBx908 GEN3), a next-generation modular switch that combines high-density performance, flexible interface modularity, and future-proof scalability in a compact 3U form factor. Customers can expand capacity on demand with a wide range of interface modules, tailoring the platform to their evolving requirements. Why SBx908 GEN3? The SBx908 GEN3 was developed in direct response to customer demand for scalable, space-efficient networking. Its capacity-on-demand model allows customers to start with only the ports
LTIMindtree Partners with Shopify to Launch an AI Commerce Center of Excellence17.9.2025 11:30:00 CEST | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced a partnership with Shopify, an AI powered commerce platform for enterprises that empowers businesses to launch, manage, and grow their online stores. Leveraging the Shopify platform, LTIMindtree will set up an AI enabled Center of Excellence (CoE) for Digital Commerce that will help global enterprises to transform at the speed of AI and innovate at scale. LTIMindtree Interactive, the AI-led agency unit of LTIMindtree, is driving the next wave of enterprise digital commerce transformation for CMOs across the globe. Shopify, trusted by millions of merchants, provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. Leveraging the Shopify platform, LTIMindtree will power an AI-driven Centre of Excellence to develop a best-in-class CoE that will: Build advanced AI commerce capabilities to help
Alpha’s latest report explores the impact of retail investors on fund finance provision17.9.2025 11:00:00 CEST | Press release
Alpha Group International plc (LON:ALPH) today announced the launch of its latest Lender Book Report, exploring and analysing the latest fund finance market trends. What does retail investment mean for subscription lines? Private capital funds, once the reserve of institutions such as pension funds and sovereign wealth funds, are rapidly opening up to a wider base of potential investors. Indeed, last month saw President Trump issue an executive order calling for expanded access to private equity and other alternative investments for 401(k) plans and their participants. While the push to open up private capital markets will undoubtedly see an influx of capital coming from new investor types, it also throws up a whole host of ramifications that need to be addressed. One of which is the impact on fund financing, namely subscription line loans. Traditionally, these facilities are secured against capital commitments from institutional investors into an alternative asset manager’s closed-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom